| PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer |
33 |
| Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder |
27 |
| Programmed Cell Death, from a Cancer Perspective: An Overview |
22 |
| Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus |
15 |
| Prognostic and Predictive Epigenetic Biomarkers in Oncology |
14 |
| Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer |
13 |
| Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA) |
13 |
| Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives |
13 |
| Molecular Diagnosis of Visceral Leishmaniasis |
12 |
| Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided? |
11 |
| Non-invasive Prenatal Testing Using Fetal DNA |
10 |
| Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing |
10 |
| MicroRNAs: Key Players in Bladder Cancer |
10 |
| The Role of DNA Methylation in Renal Cell Carcinoma |
8 |
| S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy |
8 |
| Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis |
8 |
| Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene |
7 |
| Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease |
7 |
| Emerging Biomarkers in Cutaneous Melanoma |
7 |
| The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine |
6 |
| MicroRNAs and Long Non-coding RNAs in Genetic Diseases |
6 |
| Targeting AMPK, mTOR and beta-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients |
6 |
| Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count |
6 |
| TLR4 Polymorphisms and Expression in Solid Cancers |
6 |
| Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations |
6 |
| The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I) |
5 |
| The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy |
5 |
| Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment |
5 |
| Loop Mediated Isothermal Amplification: A Promising Tool for Screening Genetic Mutations |
5 |
| Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers |
5 |
| Disruptive Technology: CRISPR/Cas-Based Tools and Approaches |
5 |
| Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases |
5 |
| Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs |
5 |
| Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes |
5 |
| Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis |
4 |
| Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis |
4 |
| Evaluation of Serum Paired MicroRNA Ratios for Differential Diagnosis of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases |
4 |
| Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia |
4 |
| Beneficial Effects of Rhodiola and Salidroside in Diabetes: Potential Role of AMP-Activated Protein Kinase |
4 |
| Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction |
4 |
| Mutational Landscape of Resistance to Thyroid Hormone Beta (RTH) |
4 |
| Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients |
4 |
| A Rapid On-Site Assay for the Detection of Influenza A by Capillary Convective PCR |
4 |
| Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential |
4 |
| Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability |
4 |
| A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention |
4 |
| Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring |
4 |
| Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome |
4 |
| The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II) |
3 |
| Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration |
3 |
